Endpoint definition
↥| Name | Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS |
|---|---|
| Long name | Special screening examination for neoplasms |
| Hospital Discharge registry | ICD-10: Z12 |
| Cause of Death registry | ICD-10: Z12 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
| Name | Z21_SPECIAL_SCREEN_EXAM_NEOPLASMS |
|---|---|
| Long name | Special screening examination for neoplasms |
| Hospital Discharge registry | ICD-10: Z12 |
| Cause of Death registry | ICD-10: Z12 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 599 | 200 | 399 |
| Unadjusted prevalence (%) | 0.28 | 0.16 | 0.42 |
| Mean age at first event (years) | 60.42 | 55.49 | 62.90 |
| Case fatality at 5-years (%) | 2.50 | 2.50 | 2.51 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 9.52 | 5.00 | 11.78 |
before Special screening examination for neoplasms
after Special screening examination for neoplasms
Loading survival analyses plot…
Loading survival analyses table…